SerratiopeptidaseThird Party Manufacturing in India

Serratiopeptidase is a zinc-containing metalloprotease enzyme belonging to the serralysin family (EC 3.4.24.40), isolated from the non-pathogenic enterobacterium Serratia marcescens. It exerts its therapeutic effects through the selective proteolytic degradation of non-living proteins and inflammatory mediators while leaving viable cells unharmed. The enzyme's active site contains a catalytic zinc ion coordinated by three histidine residues and a tyrosine residue, which facilitates the hydrolysis of specific peptide bonds. Serratiopeptidase reduces inflammation and edema by degrading key inflammatory mediators such as bradykinin, a peptide that promotes pain and swelling by increasing vascular permeability. By cleaving bradykinin and other kinins at the site of inflammation, the enzyme reduces local edema and pain. It also exhibits fibrinolytic activity by dissolving fibrin clots and denatured proteins that accumulate at sites of tissue injury. This helps in the clearance of dead tissue and promotes faster healing. Additionally, serratiopeptidase decreases neutrophil infiltration at sites of inflammation, thereby reducing the release of neutrophil-derived proteases like elastase that exacerbate tissue damage. Unlike non-steroidal anti-inflammatory drugs, serratiopeptidase does not inhibit cyclooxygenase enzymes, which means it provides anti-inflammatory effects without the gastrointestinal side effects associated with NSAIDs. The enzyme requires enteric coating for oral administration to prevent inactivation by gastric acid.

Therapeutic Uses

Serratiopeptidase is prescribed for the treatment of:

• Inflammatory Conditions: Serratiopeptidase is used for the management of acute and chronic inflammatory conditions including sinusitis, bronchitis, asthma, and chronic obstructive pulmonary disease where it helps reduce mucosal inflammation and clear respiratory secretions.

• Post-Operative Inflammation and Edema: It is widely used in surgical settings to reduce post-operative swelling, pain, and inflammation following procedures such as dental surgery, orthopedic surgery, ENT surgery, and cosmetic surgery.

• Musculoskeletal Disorders: Serratiopeptidase is effective in the treatment of conditions such as osteoarthritis, rheumatoid arthritis, back pain, cervical spondylitis, and sports injuries where it helps reduce joint inflammation and improve mobility.

• Otolaryngological Conditions: It is used in the treatment of sinusitis, otitis media, tonsillitis, and other inflammatory conditions of the ear, nose, and throat where its mucolytic and anti-inflammatory properties are beneficial.

• Traumatic Injuries: Serratiopeptidase is used to accelerate recovery from sprains, strains, contusions, and other soft tissue injuries by reducing edema and promoting the clearance of inflammatory debris.

Why Manufacturers Choose Serratiopeptidase

Serratiopeptidase is one of the most widely prescribed proteolytic enzymes in India, used extensively as an adjuvant therapy across multiple therapeutic areas including orthopedics, surgery, ENT, and dentistry. Its popularity stems from its excellent safety profile and the absence of gastrointestinal side effects that commonly limit the use of NSAIDs. Indian manufacturers produce serratiopeptidase tablets in various strengths, often combining it with other analgesics or antibiotics for enhanced therapeutic effect. The enzyme is sourced through bacterial fermentation technology and is available as a lyophilized powder for formulation into tablets. The consistent demand from the PCD franchise market, coupled with its use in hospital formularies and institutional tenders, makes serratiopeptidase a staple molecule in the Indian pharmaceutical manufacturing landscape. Its versatility in combination formulations and its well-established safety record ensure sustained demand across both domestic and export markets. This makes Serratiopeptidase one of the most sought-after molecules for third party manufacturing in India.